Recruiting

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(18 sites)

United States

UC San Diego Moores Cancer Center, La Jolla, California

University of California, San Francisco (UCSF), San Francisco, California

Mount Sinai Comprehensive Cancer Center, Miami Beach, Florida

Florida Cancer Specialists, North, St. Petersburg, Florida

Florida Cancer Specialists, East, West Palm Beach, Florida

Maryland Oncology Hematology, P.A., Brandywine, Maryland

Minnesota Oncology Hematology, P.A., Maple Grove, Minnesota

Women's Cancer Care Associates, LLC, Albany, New York

Memorial Sloan Kettering Cancer Center, New York, New York

University of Cincinnati Medical Center, Cincinnati, Ohio

Oncology Associates of Oregon, P.C., Eugene, Oregon

Northwest Cancer Specialists, P.C., Portland, Oregon

Alliance Cancer Specialists, PC, Doylestown, Pennsylvania

West Penn Hospital, Pittsburgh, Pennsylvania

Avera Cancer Institute, Sioux Falls, South Dakota

Texas Oncology - West Texas, El Paso, Texas

Texas Oncology - Gulf Coast, The Woodlands, Texas

Virginia Cancer Specialists, P.C., Fairfax, Virginia